Search
Patexia Research
Case number 2017-1115

Merck Sharp & Dohme Corp. v. Hospira, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 MERCK SHARP & DOHME CORP. v. HOSPIRA, INC. [OPINION] [precedential] (0)
Jan 25, 2018 54 Mandate issued to the United States District Court for the District of Delaware. Costs taxed in the amount of $377.84. Service as of this date by Clerk of Court. [492611] [JAB] [Entered: 01/25/2018 10:27 AM] (1)
Jan 18, 2018 53 ORDER filed denying [48] petition for panel rehearing filed by Merck Sharp & Dohme Corp.; denying [48] petition for en banc rehearing filed by Merck Sharp & Dohme Corp. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [490625] [JAB] [Entered: 01/18/2018 10:42 AM] (2)
Dec 15, 2017 52 18 paper copies of the response [51] received from Appellee Hospira, Inc. [482943] [JAB] [Entered: 12/15/2017 12:28 PM] (0)
Dec 13, 2017 51 RESPONSE of Appellee Hospira, Inc. to the petition for panel rehearing [48] filed by Appellant Merck Sharp & Dohme Corp. in 17-1115 , petition for en banc rehearing [48] filed by Appellant Merck Sharp & Dohme Corp. in 17-1115. Service: 12/13/2017 by email. [482502] [Thomas Meloro] [Entered: 12/13/2017 04:56 PM] (25)
Nov 29, 2017 50 The court invites a response from Appellee Hospira, Inc. to the petition for panel rehearing filed by Appellant in 17-1115, petition for en banc rehearing filed by Appellant in 17-1115. The response is due on or before December 13, 2017. [478892] [JAB] [Entered: 11/29/2017 12:30 PM] (1)
Nov 28, 2017 49 18 paper copies of the petition for panel rehearing [48], petition for en banc rehearing [48] received from Appellant Merck Sharp & Dohme Corp. [478693] [JAB] [Entered: 11/28/2017 03:44 PM] (0)
Nov 27, 2017 48 Petition for panel rehearing, for en banc rehearing filed by Appellant Merck Sharp & Dohme Corp.. Service: 11/27/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 11/29/2017 [478176] [Catherine Stetson] [Entered: 11/27/2017 12:28 PM] (42)
Nov 9, 2017 47 Bill of Costs for Appellee Hospira, Inc.. Service: 11/09/2017 by email. Objection to Bill of Costs due on 11/24/2017. [474370] [Thomas Meloro] [Entered: 11/09/2017 02:37 PM] (0)
Oct 26, 2017 46 OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Lourie,Circuit Judge and Hughes,Circuit Judge). Dissenting opinion filed by Circuit Judge Newman. [470701] [JAB] [Entered: 10/26/2017 09:25 AM] (21)
Oct 13, 2017 45 Notice from Appellant Merck Sharp & Dohme Corp. Regarding Expiration of Pediatric Exclusivity. Service: 10/13/2017 by email. [467733] [Catherine Stetson] [Entered: 10/13/2017 03:09 PM] (7)
Aug 7, 2017 44 Submitted after ORAL ARGUMENT by Jessica Lynn Ellsworth for Merck Sharp & Dohme Corp. and Thomas J. Meloro for Hospira, Inc. Panel: Judge: Newman , Judge: Lourie , Judge: Hughes. [451808] [JAB] [Entered: 08/07/2017 10:53 AM] (0)
Jul 11, 2017 43 6 paper copies of the Corrected Joint Appendix [32] received from Appellant Merck Sharp & Dohme Corp.. [445662] [CW] [Entered: 07/11/2017 02:16 PM] (0)
Jun 29, 2017 42 Response to oral argument order from the Appellee Hospira, Inc.. designating Thomas J. Meloro as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [443098] [Thomas Meloro] [Entered: 06/29/2017 11:56 AM] (0)
Jun 26, 2017 41 Response to oral argument order from the Appellant Merck Sharp & Dohme Corp.. designating Jessica L. Ellsworth as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [441984] [Jessica Ellsworth] [Entered: 06/26/2017 12:15 PM] (0)
Jun 21, 2017 40 Entry of appearance for Jessica L. Ellsworth as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 06/21/2017 by email. [441239] [Jessica Ellsworth] [Entered: 06/21/2017 10:40 PM] (1)
Jun 21, 2017 39 NOTICE OF CALENDARING. Panel: 1708A. Case scheduled Aug 07, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 07/17/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [441115] [JAB] [Entered: 06/21/2017 03:23 PM] (0)
May 26, 2017 38 ORDER filed. The motion [37] is granted to the extent that the oral argument will be scheduled for August 7, 2017. Service: 05/26/2017 by clerk. [434531] [LMS] [Entered: 05/26/2017 02:06 PM] (2)
May 26, 2017 37 MOTION of Appellant Merck Sharp & Dohme Corp. to expedite hearing. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/26/2017 by email. [434375] [Michael Dougherty] [Entered: 05/26/2017 10:43 AM] (9)
Mar 13, 2017 36 Notice from Appellee Hospira, Inc. regarding conflicts with oral argument (Conflicts during the days of: 4/3/17, 4/4/17, and 4/10/17). Service: 03/13/2017 by email. [415073] [Thomas Meloro] [Entered: 03/13/2017 05:30 PM] (2)
Mar 13, 2017 34 Notice from Appellant Merck Sharp & Dohme Corp. regarding conflicts with oral argument (Conflicts during the weeks of June 5-9 and August 7-11.). Service: 03/13/2017 by email. [414743] [Michael Dougherty] [Entered: 03/13/2017 10:44 AM] (2)
Mar 10, 2017 35 6 paper copies of the Corrected Joint Appendix [32] received from Appellant Merck Sharp & Dohme Corp. [414919] [KW] [Entered: 03/13/2017 02:53 PM] (0)
Mar 7, 2017 33 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 03/14/2017. [413144] [SJ] [Entered: 03/07/2017 04:04 PM] (0)
Mar 1, 2017 32 CORRECTED APPENDIX FILED for Merck Sharp & Dohme Corp. [31]. Number of Pages: 885. Service: 03/01/2017 by email. The paper copies of the brief should be received by the court on or before 03/14/2017. [413143] [SJ] [Entered: 03/07/2017 04:04 PM] (885)
Mar 1, 2017 31 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: CORRECTED JOINT APPENDIX. Service: 03/01/2017 by email. [411647] [Michael Dougherty] [Entered: 03/01/2017 12:58 PM] (885)
Feb 23, 2017 30 NOTICE OF REJECTION: The brief of Appellant Merck Sharp & Dohme Corp., Joint Appendix [29], is not in compliance with the rules of this court and is therefore rejected for filing. Appendix due 03/09/2017. Service as of this date by Clerk of Court. [409984] [SJ] [Entered: 02/23/2017 11:50 AM] (2)
Feb 21, 2017 28 Statement of Compliance with Fed. Cir. R. 33 for Appellant Merck Sharp & Dohme Corp.. Service: 02/21/2017 by email. [409262] [Michael Dougherty] [Entered: 02/21/2017 03:12 PM] (3)
Feb 21, 2017 29 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: JOINT APPENDIX. Service: 02/21/2017 by email. [409264] This appendix has been rejected. See Doc. No. [30] [Michael Dougherty] [Entered: 02/21/2017 03:17 PM] (0)
Feb 16, 2017 27 6 paper copies of the Reply Brief [26] received from Appellant Merck Sharp & Dohme Corp. [409134] [JCP] [Entered: 02/21/2017 12:39 PM] (0)
Feb 14, 2017 26 REPLY BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [25]. Number of Pages: 22. Service: 02/14/2017 by email. The paper copies of the brief should be received by the court on or before 02/22/2017. Appendix is due 02/21/2017. [407342] [SJ] [Entered: 02/14/2017 02:35 PM] (29)
Feb 14, 2017 25 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: REPLY BRIEF. Service: 02/14/2017 by email. [407308] [Michael Dougherty] [Entered: 02/14/2017 01:57 PM] (29)
Feb 2, 2017 24 6 paper copies of the Response Brief [23] received from Appellee Hospira, Inc. [404200] [KW] [Entered: 02/02/2017 01:52 PM] (0)
Jan 31, 2017 23 BRIEF FILED for Appellee Hospira, Inc. [22]. Number of Pages: 58. Service: 01/31/2017 by email. The paper copies of the brief should be received by the court on or before 02/08/2017. Appellant Merck Sharp & Dohme Corp. reply brief is due 02/14/2017. [403723] [SJ] [Entered: 02/01/2017 11:19 AM] (67)
Jan 31, 2017 22 TENDERED from Appellee Hospira, Inc.. Title: RESPONSE BRIEF. Service: 01/31/2017 by email. [403576] [Thomas Meloro] [Entered: 01/31/2017 07:33 PM] (67)
Dec 23, 2016 21 6 paper copies of the Opening Brief [19] received from Appellant Merck Sharp & Dohme Corp. [394256] [KW] [Entered: 12/23/2016 12:42 PM] (0)
Dec 22, 2016 20 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The brief [18] filed by Appellant uses a non-compliant format when referring to some appendix page ranges (Ex. "Appx1215:3-1216:2" on page 4). CORRECTION: When referring to a range of appendix pages, references to specific lines or paragraphs should not separate the pages. Line and paragraph references may be included, but they must follow after the complete page reference. For the example, the correct reference would be "Appx1215-1216." For future briefs, please ensure all appendix references follow the correct format. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [393570] [MJL] [Entered: 12/22/2016 12:29 PM] (0)
Dec 22, 2016 19 BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [18]. Number of Pages: 60. Service: 12/22/2016 by email. The paper copies of the brief should be received by the court on or before 12/27/2016. Appellee Hospira, Inc.'s brief is due 01/31/2017. [393562] [MJL] [Entered: 12/22/2016 12:21 PM] (133)
Dec 22, 2016 18 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: OPENING BRIEF. Service: 12/22/2016 by email. [393434] [Michael Dougherty] [Entered: 12/22/2016 09:47 AM] (133)
Nov 23, 2016 17 Entry of appearance for Nitya Anand as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/23/2016 by email. [385969] [Michael Dougherty] [Entered: 11/23/2016 03:40 PM] (1)
Nov 10, 2016 16 Entry of appearance for Joseph D. Eng as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382187] [Michael Dougherty] [Entered: 11/10/2016 07:14 PM] (1)
Nov 10, 2016 15 Entry of appearance for Alysia A. Finnegan as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382185] [Michael Dougherty] [Entered: 11/10/2016 07:12 PM] (1)
Nov 10, 2016 14 Entry of appearance for Raynard Yuro as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382184] [Michael Dougherty] [Entered: 11/10/2016 07:09 PM] (1)
Nov 10, 2016 13 Entry of appearance for Gerard M. Devlin as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382183] [Gerard Devlin] [Entered: 11/10/2016 07:01 PM] (1)
Nov 10, 2016 12 Entry of appearance for Tony V. Pezzano as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382180] [Tony Pezzano] [Entered: 11/10/2016 06:45 PM] (1)
Nov 10, 2016 11 Entry of appearance for Michael P. Dougherty as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382172] [Michael Dougherty] [Entered: 11/10/2016 06:14 PM] (1)
Nov 10, 2016 10 Corrected Certificate of Interest for the Appellant Merck Sharp & Dohme Corp.. Service: 11/10/2016 by email. [382054] [Catherine Stetson] [Entered: 11/10/2016 02:37 PM] (1)
Nov 9, 2016 9 Docketing Statement for the Appellee Hospira, Inc.. Service: 11/09/2016 by email. [381797] [Thomas Meloro] [Entered: 11/09/2016 05:07 PM] (4)
Nov 9, 2016 8 Certificate of Interest for the Appellee Hospira, Inc.. Service: 11/09/2016 by email. [381796] [Thomas Meloro] [Entered: 11/09/2016 05:05 PM] (2)
Nov 9, 2016 7 Entry of appearance for Michael W. Johnson as of counsel for Appellee Hospira, Inc.. Service: 11/09/2016 by email. [381794] [Michael Johnson] [Entered: 11/09/2016 05:02 PM] (2)
Nov 9, 2016 6 Entry of appearance for Thomas J. Meloro as principal counsel for Appellee Hospira, Inc.. Service: 11/09/2016 by email. [381792] [Thomas Meloro] [Entered: 11/09/2016 04:59 PM] (2)
Nov 9, 2016 5 NOTICE OF DEFICIENCY: The certificate of interest Document No. [3] filed by Appellant Merck Sharp & Dohme Corp. in 17-1115 is incomplete [question 2] and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [381785] [SJ] [Entered: 11/09/2016 04:44 PM] (0)
Nov 9, 2016 4 Docketing Statement for the Appellant Merck Sharp & Dohme Corp.. Service: 11/09/2016 by email. [381686] [Catherine Stetson] [Entered: 11/09/2016 02:35 PM] (3)
Nov 9, 2016 3 Certificate of Interest for the Appellant Merck Sharp & Dohme Corp.. Service: 11/09/2016 by email. [381684] [Catherine Stetson] [Entered: 11/09/2016 02:33 PM] (0)
Nov 9, 2016 2 Entry of appearance for Catherine E. Stetson as principal counsel for Appellant Merck Sharp & Dohme Corp.. Service: 11/09/2016 by email. [381679] [Catherine Stetson] [Entered: 11/09/2016 02:31 PM] (1)
Oct 26, 2016 1 Appeal docketed. Received: 10/24/2016. [377663]Entry of Appearance due 11/09/2016. Certificate of Interest is due on 11/09/2016. Docketing Statement due 11/09/2016. Appellant/Petitioner's brief is due 12/27/2016. [SJ] [Entered: 10/26/2016 09:49 AM] (28)
Menu